MAPT and Alzheimer disease: Aligned with the previous study which found that a higher level of TG may be a protective factor of dementia development [34], the negative correlation between TG and CSF t‐tau and p‐tau 181 in APOE ε4+ AD subgroup indicated that TG may delay the AD progression by protecting neurons from damage and degeneration.